Journal
BIOCHEMISTRY AND CELL BIOLOGY
Volume 88, Issue 4, Pages 559-564Publisher
CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
DOI: 10.1139/O09-160
Keywords
choline kinase; phosphatidylcholine; embryonic lethality; muscular dystrophy; cancer
Categories
Funding
- Canadian Institutes of Health Research [MOP 5182] Funding Source: Medline
Ask authors/readers for more resources
Choline kinase (CK) was discovered in 1953 Progress in understanding the function of CK was slow until its purification in 1984 The subsequent cloning and expression of the cDNA led to the description of the gene structures Two genes encode choline kinase, Chka and Chkb, and 3 isoforms of the enzyme have been identified - CK alpha-1, CK alpha-2, and CK beta - and the active form of CK is a hetero- or homo-dimer. More recently, gene-disrupted mice have been described Mice that lack CK alpha die early in embryogenesis. In contrast, mice that lack CK beta survive to adulthood, but develop hindlimb muscular dystrophy and forelimb bone deformity It has been shown that this hindlimb muscular dystrophy is due to decreased biosynthesis of phosphatidylcholine and increased catabolism of phosphatidylcholine in the hindlimbs, but not the forelimbs. of mice CK and its product phosphocholine have also been implicated in development of numerous cancers Thus, a possible treatment for some kinds of cancer may involve drug inhibition of CK or targeting the expression of CK with RNA interference In the mid 1950s it was clear that CK was important for the biosynthesis of phosphatidylcholine, but no one predicted a role for CK in muscular dystrophy, bone deformities, or cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available